MS-275, a HDAC inhibitor, inhibits the tumor spheroid formation of ovarian cancer cells and impacts on Talin‐1‐α5β1‐integrin‐mediated actin cytoskeleton and extracellular matrix protein remodeling 23. This evidence concerns the gene TLN1 and neoplasm.